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Abstract 
Patients with autoimmune rheumatic diseases are at high risk for infections. Currently 6 vaccines are 
recommended by the Advisory Council on Immunization Practices for routine immunization of 
immunocompromised adults in the United States: influenza, tetanus/diphtheria/pertussis, herpes zoster, 
human papilloma virus, and two pneumococcal vaccines. Levels of vaccination coverage for all adults in 
the United States are below target; paradoxically, despite their increased susceptibility to infection and 
risk of complications, the levels of vaccination coverage for patients with immune mediated inflammatory 
diseases are even lower than in the general population. A quality improvement project was conducted in 
order to overcome system barriers and improve influenza and pneumococcal vaccination coverage in this 
vulnerable population. 
Keywords:  Vaccination, Quality Improvement, Autoimmune, Rheumatology, Immunosuppressed 
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Improving Vaccination Coverage in an Adult Ambulatory Rheumatology Clinic through a  
Quality Improvement Process 
 
Section One: Nature of the Problem 
Introduction to the Problem 
Vaccines are underutilized in the United States adult population (Centers for Disease Control and 
Prevention, 2018; Heyman et al., 2008), including in rheumatology clinics (Curtis et al., 2010; Yun et al., 
2016). Having worked in such a setting for over 19 years, the author has seen far too many patients with 
compromised immune systems suffer with complications from vaccine-preventable illnesses such as 
influenza and pneumonia. In addition to the personal and professional feelings of regret and responsibility 
that are experienced by health care providers when patients have less than optimal outcomes, there is also 
a significant financial burden that comes with these illnesses which can be measured in the billions of 
dollars annually (Ozawa et al., 2016).  Various researchers have studied and identified reasons for missed 
opportunities for vaccination in patients with rheumatic diseases (Johnson et al., 2008; Kimoto et al., 
2016; Sandler et al., 2014; Taddio et al., 2012; Zimmerman et al., 2003). Many methods have been 
utilized in an attempt to overcome barriers to vaccination in healthy adults (Dexter et al., 2004; A. X. 
Garg et al., 2005; Kiefe et al., 2001; Milkman et al., 2011; Nichol, 1998; Stone et al., 2002; Szilagyi et al., 
2000) as well as immunocompromised adults (Baker et al., 2016; Bays et al., 2015, 2016; Sonali P. Desai 
et al., 2013; Dudley et al., 2014; S. Garg et al., 2016, 2018; Kimoto et al., 2016; Ledwich et al., 2009; 
Schoenfeld et al., 2014; Sheth et al., 2017). This project proposed to increase vaccination coverage in an 
adult rheumatology clinic by identifying and overcoming systems barriers to vaccination.  
Purpose of the Project 
According to the Centers for Disease Control and Prevention (CDC), there are over 5 million 
adults in the United States living with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis 
(Center for Disease Control and Prevention (CDC) & National Health and Nutrition Examination Survey 
Data, 2019). Another 320,000 have definite or probable systemic lupus erythematosus (Centers for 
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Disease Control and Prevention (CDC), 2018), and there are many more individuals diagnosed with the 
less common rheumatic diseases such as vasculitis, mixed connective tissue disease, autoimmune 
myopathies, systemic sclerosis, and Sjögren’s Syndrome. These patients, due to the nature of their 
diseases as well as the immunosuppressant medications that are often prescribed for them, are at higher 
risk for infection and complications from infection than the general population and therefore are sorely in 
need of protection from communicable diseases (Listing et al., 2013; Müller-Ladner & Müller-Ladner, 
2013; Rubin et al., 2014).  
Currently six vaccines are recommended by the Advisory Council on Immunization Practices 
(ACIP) for routine immunization of immunocompromised adults in the United States: influenza, 
tetanus/diphtheria/pertussis (TDaP), herpes zoster, human papilloma virus, and two different 
pneumococcal vaccines (Advisory Committee on Immunization Practices, 2019). These recommendations 
differ from those for healthy adults in that certain vaccines (measles, mumps, rubella, varicella) are not 
recommended because they are live attenuated, whereas other vaccines (pneumococcal polysaccharide, 
pneumococcal conjugate) are recommended at a younger age. Levels of vaccination coverage for all 
adults in the United States are below target (National Vaccine Program Office, 2019); paradoxically, 
despite their increased susceptibility to infection and risk of complications, the levels of vaccination 
coverage for patients with immune mediated inflammatory diseases (IMIDs) are even lower than in the 
general population (Curtis et al., 2010; Yun et al., 2016). From 1999-2006, only 33% of eligible patients 
with rheumatoid arthritis and psoriatic arthritis in a study that examined nearly 150,000 patients from the 
Medicare Chronic Conditions Warehouse received pneumococcal vaccines, and only 20% received 
influenza vaccines all five years of the study (Curtis et al., 2010).  
The cost of this lack of protection is shared by all members of society in terms of actual dollars 
spent as well as utilization of finite healthcare resources. In terms of finances, the burden of vaccine-
preventable illness in the United States is high (Ozawa et al., 2016). The economic burden for influenza in 
the United States in 2015 was $5.79 billion and for pneumococcal disease it was $1.86 billion (Ozawa et 
al., 2016). While it is true that not all of these costs were incurred by patients with IMIDs, clearly they 
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represent a target population for intervention. Besides the economic burden, these barriers also have an 
impact on the quality of healthcare as proposed by the National Academy of Medicine (Institute of 
Medicine (US) Committee on Quality of Health Care in America, 2001). Some of the barriers identified 
in the literature, such as fear of side effects and belief by patients that they do not need immunization, 
may be overcome simply with patient education and are not intrinsically part of the process that results in 
lower quality of care. Other barriers, however, can be directly related to quality outcomes. A selection is 
presented in Table 1. The relationship of these barriers to each of the six domains of healthcare quality 
put into perspective just how far-reaching one intervention (or lack thereof) can be for an individual as 
well as a healthcare system.  
The objective of this DNP quality improvement (QI) project was to increase vaccination coverage 
in immunosuppressed patients. The process through which this objective was accomplished was the 
implementation of interventions to overcome systems barriers to vaccination in an adult ambulatory 
rheumatology clinic. Outcomes were measured in terms of changes to the percent of patients up to date on 
vaccinations over predetermined time periods. 
 
 
 
 
 
 
 
 
 
 
 
 
IMPROVING VACCINATION COVERAGE 6 
 
Table 1: Examples of Barriers to Vaccination and How They Affect Healthcare Quality 
Domain Barrier Relationship 
Patient safety 
 
 
Knowledge gaps Providers cannot deliver safe 
care if they are unaware of 
guidelines 
Effective Lack of processes 
 
Haphazard approach leads to 
missed opportunities and lack of 
efficacy 
Patient-centered Lack of time Provider lack of time results in 
possible harm to patient 
Timely 
 
 
Missing records 
 
Lack of reminders 
 
Having to collect records can 
cause a delay in vaccination 
Missing window of opportunity 
for time-sensitive vaccines can 
result in decreased efficacy 
 
Efficient 
 
Equitable 
Vaccine not stocked 
 
Cost to patient 
Increases burden to patient to 
have to make >1 trip  
Patients with insurance coverage 
or funds to pay for vaccines 
receive higher quality care than 
patients without coverage/funds.   
   
Note:  The National Academy of Medicine proposed the six domains of health care quality in order to 
guide development initiatives and for all stakeholder to be better able to understand the relevance of 
quality (Agency for Healthcare Research and Quality, 2018). This table takes some of the commonly 
reported barriers to vaccination and relates them to quality domains. 
Section Two: Review of the Literature 
There is an abundance of literature related to the topic of QI in immunizations. Interventions to 
improve vaccination coverage range from patient-focused to provider-focused, rudimentary to high-tech, 
directed towards pediatric or adult patients, and many other approaches and variations. The literature 
search for this project was crafted to provide results which were timely and relevant. Results were then 
carefully evaluated in order to identify publications that were scientifically grounded, relevant to the 
investigator’s target population, and reproducible in the proposed setting.  
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Clinical practice problem statement 
In adult patients on immunosuppressive medications seen in an outpatient rheumatology 
clinic (P), how do prepopulated orders attached to care gap alerts in the EMR, a team approach, 
and optimization of workflow using a centralized notification board (I) compared to individual 
provider practice (C) affect levels of vaccination coverage (O)? 
Evaluation/Summary of the evidence from the literature 
Literature searches of PubMed, Cochrane, and Scopus were performed using the following search 
terms in various combinations: vaccine, rheumatic disease, barriers, quality improvement, and 
immunosuppressed. Several limits were applied including human-only, full text available, English 
language, and, in PubMed, limit to last 10 years. Thirty-five additional records were found via a search of 
the American College of Rheumatology (ACR) website using the same search terms with the exception of 
rheumatic disease; this search was limited to the last 10 years.  
Identification 
The first stage of the literature search resulted in 843 citations:  PubMed 663 articles, Cochrane 
Library 134 articles, Scopus 46 articles.   
Screening 
Based on their titles alone, 126 out of 134 Cochrane results were immediately deemed irrelevant 
and discarded. Nine of the 46 Scopus results appeared to be applicable based on their titles and abstracts. 
97 of the original 663 PubMed results survived the first screening round. 115 entries in total were entered 
into an Excel Spreadsheet (Appendix F). Three duplicate entries were removed, leaving 112.  The 
abstracts for the remaining 112 articles were reviewed; 34 were deemed relevant enough to warrant 
further investigation. The other articles were discarded for various reasons as detailed in a Consort 
flowchart (Figure 1). 
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Figure 1: Consort flowchart of literature review 
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Thirty-four full-text articles and all 35 additional records were reviewed for eligibility. Of these, 
24 articles were found to be relevant in terms of basic QI processes but were not specific to a 
rheumatology or immune-mediated inflammatory disease setting. These 24 articles were retained for 
background and significance reasons but were not assessed via synthesis or evaluation tables. 13 
additional records were relevant in terms of the current project. 
Included 
A total of ten journal articles that were deemed to be appropriate and relevant were identified 
through this literature search (Baker et al., 2016; Chow & Shojania, 2017; S. P. Desai et al., 2011; Sonali 
P. Desai et al., 2013; S. Garg et al., 2018; Harris et al., 2015; Karr et al., 2016; Ledwich et al., 2009; 
Parker et al., 2013; Sheth et al., 2017). In addition 13 abstracts from ACR annual meetings held between 
2012 and 2018 were selected by the author for inclusion in a synthesis table (Aguirre et al., 2017; Bays et 
al., 2015, 2016; Bussey & Ostrowski, 2014; S. Desai et al., 2012; Dudley et al., 2014; S. Garg et al., 
2016; Goodson et al., 2018; Margaretten et al., 2015; O’Brien & Schmidt, 2017; Ostrowski & Chaudhry, 
2016; Schoenfeld et al., 2014; Swee et al., 2018). The 10 articles are summarized in the evaluation and 
synthesis tables (Appendices A and B); the 13 ACR abstracts are summarized in a synthesis table 
(Appendix C).  
Critical appraisal of the evidence 
The ten articles included in the evaluation table all advanced through the first several rounds of 
narrowing down the literature search; a deeper reading of each article revealed strengths and weaknesses 
in each.  
The quality of the evidence was evaluated using a rapid critical appraisal (RCA) tool (Melnyk & 
Fineout-Overholt, 2015) and was found to be excellent in all 10 articles. The few lapses in quality that 
were identified were mostly due to gaps in data collection or analysis. Even these gaps provided a 
learning experience for the reviewer; knowing that other practitioners had problems with EMR queries 
provided advance notice of how to structure future queries in such a way that certain subsets of patients 
are not missed. Another area for improvement gleaned from the evidence was how to handle vaccination 
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prompts that were ignored or bypassed by clinicians. During one project (Sheth et al., 2017), over 40% of 
the alerts that were fired by the EMR were bypassed by the physician seeing the patient. Had the project 
been designed differently, those dismissed alerts could have provided an opportunity to reeducate 
providers in real time in order to improve the vaccination process. 
Some of the major points that stand out from the evaluation and synthesis tables are that projects 
utilizing at least two of the three interventions (use of EMR, process change, team approach) resulted in 
more positive results. Interventions that used only one type of intervention had the lowest increases in 
vaccination.  
Presentation of theoretical basis 
As immunizations fall under the domain of public health, it is appropriate to base a QI project that 
attempts to improve vaccination coverage on a public health theoretical model. One such model is the 
Health Belief Model (HBM), which was developed in the 1950s by social psychologists from the US 
PHS, including Irwin Rosenstock, Godfrey Hochbaum, Stephen Kegeles, and Howard Leventhal. It is one 
of the oldest, most well-known, and most widely used health behavior theories. It was originally 
developed to try to determine why free, public tuberculosis screening efforts were failing. The creators of 
the model believed that providers can’t convince the public to change their health behaviors until they 
understand why individuals behave the way they do (Irwin M. Rosenstock, 2005).  
The main assumption of the HBM is that individuals act when they perceive a threat to their 
personal health and when they have the conviction that the benefits of health-promoting activities will 
outweigh the expense of following through with the action (I. M. Rosenstock et al., 1988). For this project 
the HBM was adapted slightly in that it is modification of the behaviors of the clinicians, not patients, 
which is the objective.  
There are four original constructs of the HBM: perceived severity, perceived susceptibility, 
perceived benefits, and perceived barriers (I. M. Rosenstock et al., 1988). Examples of each construct in 
terms of vaccination are shown in Table 2. Both the traditional (patient) and adapted (provider) 
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perspectives are shown in the table, illustrating how the constructs can act as motivation to act for each 
group. 
It is not enough for a QI project to be grounded in a proven theoretical framework; it must also 
conform to the overall mission of the setting in which the project takes place. The mission statement of 
the large Midwestern academic medical center where this project took place is “To provide better care of 
the sick, investigation in their problems and further education of those who serve.” By exploring why 
providers fail to protect their patients through immunization, and overcoming those barriers through EBP, 
this project fulfilled all three parts of the institute’s mission. 
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Table 2: Application of the Health Belief Model 
 Patient Provider 
Perceived Severity 
 
 
 
 
 
Perceived Susceptibility 
 
 
 
 
 
 
 
 
 
 
Perceived Benefits 
 
 
 
 
 
 
 
 
Perceived Barriers 
 
How bad is the illness?  
Can it kill me? 
 
 
 
 
How common (or rare) is the illness?  
Can I really catch it? 
 
 
 
 
 
 
 
 
How effective is the vaccine?  
Will I be protected?  
Will I be protecting others? 
 
 
 
 
 
 
Will my insurance cover it?  
How badly will it hurt? 
Will it make me sick?  
 
 
How bad is the illness?  
Could the patient become 
severely ill? 
Could this illness kill this patient? 
 
Are we in a high-incidence area?  
Is my patient planning on 
traveling to an endemic area? 
Does this patient work in a high-
risk setting? 
What medications is my patient 
on that could make him or her 
more susceptible to this illness? 
 
What are the efficacy rates? 
What medications might affect 
efficacy? 
Even if the vaccine is not 100% 
effective, will my patient benefit 
in terms of lower morbidity? 
 
I don’t have time to get into a 
risk/benefit discussion with every 
patient/find the MA. 
My patient doesn’t have time to 
wait. 
Will insurance cover it? 
Are there medical 
contraindications? 
This EMR is a pain to figure out – 
there are too many options! 
 
 
Utility/Feasibility 
Improving vaccination coverage in immunosuppressed patients is not only applicable in the 
rheumatology setting, it is a professional imperative. Patients come to rheumatology with derangements 
of their immune systems. Simply having an IMID puts them at higher risk for infection. The medications 
that are used to attempt to control IMIDs are immunomodulators and immunosuppressants; in effect, 
rheumatology providers take immunologically vulnerable patients and make them more vulnerable. There 
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is a professional duty to protect these patients from infectious diseases whenever possible. However, if 
protecting patients in this way were easy, it would already be happening and there would be no need for a 
QI project. Any immunization project has financial costs and costs in terms of time utilization, and this 
project was no exception. One cost that did not have to be considered was the cost of the vaccines 
themselves; they were already stocked regularly and built into the department budget. Billing for the 
vaccines and administration was already set up in the EMR. The costs of having a pharmD on the QI team 
were also already accounted for, as the Department of Pharmacy provides a full time pharmacist to the 
department. One of the goals of having an embedded pharmacist is participation in QI projects, therefore 
her time and expertise were already covered financially. Time involvement is a major consideration; 
physicians and advanced practice provider (APPs) are granted 10% protected time in which to do projects 
such as these, but the medical assistants (MA) had no such flexibility in their schedules. Pulling them 
away from clinic in order to help design this or any QI project was a cost to consider, as the MAs not 
directly involved with the planning of the project had to room their patients, assist with procedures, and 
otherwise cover for them.  
 Due to the existing infrastructure and the fact that this project was geared towards increasing the 
use of materials which were already considered standards of care (SOC), it was anticipated that the 
overall financial cost of this project would be low. A proposed budget (Table 5) and timeline (Figure 5) 
are presented in Section 3. 
Recommendations summary 
According to the literature, the most successful intervention by far is organizational change; in 
the meta-analysis mentioned above, the odds ratio of the effectiveness of organizational change for 
improvement of vaccine uptake was 16.0 (Stone et al., 2002). The components of organizational change 
mentioned in the meta-analysis and other studies include standing orders, the establishment of prevention 
clinics, and designation of specific prevention responsibilities to non-provider staff (Bays et al., 2016; 
Bridges et al., 2015; Nichol, 1998; Stone et al., 2002).  Provider education, but not provider feedback, 
was also found to be modestly effective (Bays et al., 2016; Bridges et al., 2015). Patient reminders are 
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only modestly successful in improving vaccination uptake in adults according to a Cochrane Review 
(Jacobson Vann et al., 2018),   but another systematic review found increases in vaccination rates of 5-
20% in patients who received any type of reminder or recall intervention (Szilagyi et al., 2000).  
Similar to what the evidence shows for success in intervention type, the most successful 
intervention feature for improving immunization coverage is collaboration and teamwork. The adjusted 
odds ratio of this feature was 17.9; the next highest feature on the list was “high visual appeal and clarity” 
(of materials used during the intervention), which had an adjusted odds ratio of 3.25 (Stone et al., 2002). 
While still a statistically significant increased effect, it is clear that teamwork provides a much higher 
yield in terms of improvement of vaccination coverage. 
The strongest recommendations gleaned from the literature review are as follows:  
 Use a team-based approach (S. Garg et al., 2018; Harris et al., 2015)  
 Streamline workflow (Sonali P. Desai et al., 2013; S. Garg et al., 2016; Sheth et al., 2017)  
 Utilize orders attached to an alert in the EMR (Baker et al., 2016; Karr et al., 2016; 
Ledwich et al., 2009; Sheth et al., 2017)  
The key stakeholders in this provider-based intervention were the rheumatology providers 
(physicians and APPs) and the MAs who administer vaccines. The department IT analyst’s expertise on 
the implementation of Care Gap Alerts (CGAs) in the existing EMR made her a key stakeholder as well. 
The main strategy to engage the key stakeholders was a presentation made by the author at a monthly 
staff meeting. This presentation included the baseline levels of vaccine coverage, the consequences of 
vaccine preventable illnesses, an overview of the immunization CGA, and an explanation of the new 
process to alert MAs that a vaccine has been ordered (the whiteboard).  
Potential barriers included provider resistance to having to address a CGA during a 20 minute 
follow up visit, provider confusion regarding safety and timing of vaccines, confusion over the new 
workflow, and MA reluctance to change the vaccination process. Strategies to address these barriers 
included appealing to providers’ sense of duty to protect a vulnerable population, emphasizing that 
spending the time to prevent infections would likely save a much greater amount of time spent dealing 
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with an illness in the future, making the process as easy as possible, reminding providers that the 
rheumatology pharmacist is always on site to answer any questions about vaccine appropriateness, and 
illustrating to the MAs that the new process was more centralized than the current process. 
Section Three: Methods 
Recommendations for implementation of practice change 
As seen in the evaluation and synthesis tables, many methods have been utilized in an attempt to 
overcome barriers to vaccination. In addition, a meta-analysis published in 2002 reviewed, categorized 
and distilled data covering 83 different interventions from 29 trials to that date and made clear, 
hierarchical, evidenced-based recommendations for clinical use (Stone et al., 2002). These 
recommendations are borne out by the more recent evidence gathered for this project. 
Barriers to vaccination which were identified in outpatient rheumatology clinics include provider 
knowledge gaps, missing records, lack of reminders, lack of time, lack of processes of care that facilitate 
immunization, fear of side effects, vaccine not stocked, absence of recommendation by provider, costs, 
lack of vaccine requirements for adults, and belief by patients that they do not need immunizations 
(Bridges et al., 2015; Dudley et al., 2014; Gannon et al., 2012; S. Garg et al., 2016; Johnson et al., 2008; 
Sandler et al., 2014). 
According to the literature reviewed for this project, four main factors contribute to the problem 
of low levels of vaccination coverage in an ambulatory specialty clinic: individual (the ordering and 
administrating clinicians), patient, organizational (systems for identifying eligible patients), and task 
(procedures for ordering and administrating vaccines). Many conditions may contribute to missed 
opportunities for vaccination including lack of time, lack of space (exam rooms), and lack of actual 
vaccine. The areas that afforded the greatest opportunity for improvement were the focus of this QI 
project: individual, systems, and task. 
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Plan for implementation of the EBP practice change 
Practice Setting 
The setting for this project was the Main Campus location of the outpatient rheumatology 
department of a large Midwestern hospital. Approximately 500 patients with a variety of rheumatic and 
immunologic diseases are seen in this department per week. All patients with these diseases who are on 
immunosuppressive treatment are at risk both for contracting and experiencing higher rates of 
complications from vaccine-preventable diseases such as influenza and community acquired pneumonia  
(Listing et al., 2013; Müller-Ladner & Müller-Ladner, 2013; Rubin et al., 2014). These types of patients 
are similar or the same as those from the cited studies examining levels of vaccination coverage and 
opportunities for improving them. Vaccinations for influenza and pneumonia were already routinely 
stocked in the department and all members of the clinical team were familiar with their storage and 
administration.  
The facts that a) this patient population is in need of vaccinations, b) vaccinations are available 
and part of the standard of care, c) levels of vaccine coverage are below target, and d) recommendations 
for interventions in similar types of patients exist made this setting appropriate for the proposed quality 
improvement project. 
Readiness for Change 
Many stakeholders were affected by the practice changes of the QI project. Medical assistants 
were asked to change their workflow; providers’ workflow in the EMR and after the visit were altered. 
The rheumatology department’s readiness to change was assessed using the New Idea Scorecard (Fraser, 
2019) (Appendix D). The core group of six stakeholders completed the assessment. There was broad 
agreement across all attributes and interventions. The majority of interventions received scores of 4 
(“change is strong relative to this attribute”) or 5 (“change is very strong relative to this attribute”). This 
was not the case for the intervention of “documentation”, which was given a score of 3 for many 
attributes by most of the stakeholders. Further discussion revealed that what “documentation” meant was 
unclear to the stakeholders. After it was explained that documentation will be attached to the CGA (for 
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ordering) and unchanged (for administration), all stakeholders welcomed the change and felt it would be 
accepted by the department. 
Summary of the Plan 
In order to improve vaccination coverage in an outpatient clinic, the baseline rates must be 
known. The first step is to decide which records to include in the analysis. The recommendations from 
ACIP are not disease-specific; rather, they are based on immunosuppression. As part of the feasibility 
assessment of the project the author submitted a request to the institution’s information technology 
division (ITD) to query the EMR. The gatekeeper to data is the application analyst. She fields all requests 
for database mining and assesses them for appropriateness to clinical care while also checking for any 
possible patient privacy concerns. This query identified patients seen in the adult rheumatology clinic 
between 9/1/2017 and 8/31/2018 who were prescribed disease modifying antirheumatic drugs, both 
traditional (DMARD) and biologic (bDMARD) (Table 3).  
 
Table 3: Medications included in baseline query 
 
The EMR database was then instructed to take this master list of immunosuppressed 
rheumatology patients and search for records of influenza, TDaP, herpes zoster recombinant, 
pneumococcal conjugate, and pneumococcal polysaccharide vaccinations (Table 4). 
Medication (DMARD) Medication (bDMARD) Medication (small molecule) 
   
Azathioprine 
Cyclophosphamide 
Leflunomide 
Methotrexate 
Mycophenolate Mofetil 
Prednisone 
 
 
Abatacept 
Adalimumab 
Anakinra 
Belimumab 
Certolizumab 
Etanercept 
Golimumab 
Infliximab 
Rituximab 
Sarilumab 
Secukinumab 
Tocilizumab 
Ustekinumab 
Baricitinib 
Tofacitinib 
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Table 4: Vaccinations and parameters included in baseline query 
 
 
 
 
 
 
 
  
These data were provided to the author in a spreadsheet, which was then stored on a secure drive. 
One vaccine, zoster recombinant, only recently became available and has not been studied for either 
safety or efficacy in patients with autoimmune disease; therefore the rates for zoster vaccine were 
collected, but were not included in the intervention at this time. Another vaccine, human papilloma virus 
(HPV), was approved in 2018 for adults up to age 45 (U.S. Food & Drug Administration, 2018); because 
this approval was so new at the time of this project and there are many unknowns related to cost, 
insurance coverage, and use in adult patients on immunosuppressive medications, HPV vaccination was 
also not included. Finally, although TDaP vaccination rates were collected, there is no nationally 
recognized benchmark for TDaP coverage. With no established benchmark to measure against, TDaP was 
deemed inappropriate for a QI project. The three ACIP-recommended vaccines that remained and 
included in the QI project were influenza, PCV-13, and PPSV-23. 
An evaluation of baseline levels of vaccination coverage in the proposed study site revealed that 
for the one year period that was studied, coverage was well below targets. Healthy People 2020 calls for 
70% coverage for influenza and 90% coverage for pneumonia (Offices of Disease Prevention and Health 
Promotion, 2019a). The rates for all patients who fit the query criteria were PCV-13 10.3%, PPSV-23 
25.5%, and influenza 8.7% (Figure 2). Appendix E breaks down vaccination coverage by medication 
used. 
Vaccines Visit parameters 
  
Influenza (High Dose Influenza 
Vaccine, or Influenza Virus 
Split) 
Pneumococcal-13 (PCV-13, 
Prevnar™) 
Pneumococcal-23 (PPSV 23, 
Pneumovax™) 
Tdap (TDAP vaccine age 7+ 
IM,  Adacel™) 
Zoster vaccine recombinant, IM 
(Shingrix™) 
Zoster vaccine live, sub-Q 
(Zostavax™) 
Main Campus  
Adult Rheumatology 
Outpatient Clinic 
Sept 1, 2017 – Aug 31, 2018 
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Figure 2: Baseline Vaccine Data 
 
After determining the baseline rates of vaccination for patients on immunosuppressive 
medications, the next step was to continue planning the change by deciding on an intervention. As 
described above, the strongest recommendations gleaned from the literature review are to use a team-
based approach, streamline workflow, and utilize orders attached to an alert in the EMR, typically via a 
best practice alert (BPA). A BPA is a tool within the EMR that notifies clinicians when they need to tend 
to an important task. Once a BPA fires, it must be actively addressed or dismissed in order to continue 
working in the patient’s record. 
In order to follow the recommendation from the literature of utilization of alerts and orders in the 
EMR, a scheduled institution-wide upgrade that coincided with the QI project was taken advantage of. 
While the new version of the institution’s EMR does not incorporate BPAs, it does utilize care gap alerts 
(CGAs) which are similar in many important ways. CGAs, like BPAs, are automatically launched on the 
home screen once a patient record is opened. In addition, CGAs, like BPAs containing order sets, have a 
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prepopulated order attached meaning the provider does not have to complete a separate task to order a 
vaccine after opening the CGA. One restriction that is inherent to CGAs compared to BPAs is that the 
CGAs currently in use at the project site are not modifiable; they only launch when an intervention is 
appropriate based on preset guidelines that do not, at this time, include immunosuppression. This factor 
does not alter the utility of CGAs for alerting providers to the need for influenza vaccine, since this 
vaccine is recommended for all adults by ACIP. However, pneumonia vaccines are universally 
recommended only for adults 65 years of age and older. Since these recommendations would not be 
tailored to meet the ACIP recommendations for immunosuppressed patients, CGAs were not part of the 
QI project plan for pneumonia vaccination. Based on this evidence and the inherent restrictions in the 
institution’s EMR, this QI project utilized an existing CGA coupled with the use of workflow 
optimization for influenza vaccines, and workflow optimization alone for pneumonia vaccines. 
The other two of the three recommendations were achieved by building a small core team of two 
physicians, two APPs, and two MAs in order to address current workflow issues. This team met on three 
occasions to discuss problems with the current vaccination process and brainstorm ideas for how to make 
it work better for all team members. Prior to this project, the methods for a provider to notify an MA that 
a vaccine was needed were to either hang a tag from the door flags, page the MA, or walk around the 
department looking for the MA. All team members agreed that the hanging tags were the most convenient 
for the provider but the least convenient for the MA and the least efficient for the patient; if the MA was 
in an exam room in another hallway rooming patients, it could take 15-20 minutes before she happened to 
walk down the hall where the tags were hanging. Paging the MA was disruptive to the workflow, as MAs 
are assigned to 3-5 providers each day and room patients and assist with joint injections. Walking around 
looking for the MA was obviously frustrating and time-consuming for the provider. 
The proposed new workflow involved installation of 2 whiteboards on either end of the 
centralized nurse’s station, which connects the two exam room hallways in the department. After the 
provider was done seeing the patient, he or she wrote down the vaccine and room number on the 
whiteboard. Any available MA was then responsible for administering the vaccine. The previous and 
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proposed workflows are outlined in figures 3 and 4. After the new workflow was decided upon, a timeline 
was presented to the Department Chair and part of the monthly staff meeting was allotted for presentation 
of the project to all members of the department. 
 
Figure 3: Current Provider Workflow 
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Figure 4: Proposed Workflow 
 
 
The go-live date for the hospital-wide EMR upgrade was in early November, which was 
coincidentally the same week as the American College of Rheumatology annual meeting. Almost all 
providers attended the meeting and were not on campus for the go-live. Therefore, the whiteboards were 
installed and ready to use the week after the EMR upgrade, when the rheumatology department was again 
fully staffed.  
At weeks 4, 8, and 12 after launch, the same terms/parameters that were used for baseline data 
gathering (with the exception of the date range) were used by the ITD analyst to request vaccination data 
for patients seen during the previous 4 weeks. 
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Measurement Methods 
Outcomes measurement 
An increase in vaccination coverage was chosen as the indicator that the QI project was 
successful. While the bar set by Healthy People 2020 was the ultimate goal, any improvement in the 
number of patients up to date on vaccinations over the course of this project was welcomed. An 
improvement of only 10% over 12 weeks signifies that hundreds more immunosuppressed patients were 
protected from influenza and pneumonia compared to the time prior to the interventions. 
Instruments used 
Baseline vaccination coverage levels were compared to Healthy People 2020 targets as well as 
each of the 3 monthly intervals.  
Why this measure is appropriate 
Healthy People 2020 establishes benchmark goals for many conditions, diseases, and preventive 
measures. It is a collaboration between several federal agencies with scientific expertise in relevant fields 
(Offices of Disease Prevention and Health Promotion, 2019b). The goals for influenza and pneumococcal 
vaccination are well-established and therefore appropriate goals for this project.  
Data collection process 
As explained above, the gatekeeper to data is the application analyst. Given that the application 
analyst fields requests from an entire institute and is also responsible for training coordination, her time is 
very limited. It was anticipated that this would be a major barrier to data collection for the project. 
Despite scheduling meetings as far in advance as possible and being aware of major EMR upgrades and 
downtimes, this limitation did prove to be significant and it took several weeks to receive query results 
from the database team. 
Data analysis plan 
Given that the data analysis consisted of a simple pre- and post-intervention comparison, it was 
not anticipated that complex statistical analyses would be needed for this project. Once vaccination 
coverage rates were collected, the percentage change was compared to baseline and HP2020 benchmarks 
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in order to determine if the new processes should remain in place or if further interventions were 
necessary.   
Proposed budget, time, and resources plan 
The financial cost of this project was anticipated to be minimal. The vaccines are stocked in the 
department, the personnel were in place, and meeting/educational materials were in electronic format, 
eliminating the need for printing costs. The greatest expense by far was the mandatory fee charged by the 
organization’s Nursing Research Office, which covers the time of a senior nurse researcher for guidance 
as well as IRB submission. 
Table 5: Proposed budget of QI project 
QI  project element Cost charged to project 
 
Provider time to order vaccine  
MA time to administer vaccine(s) 
ITD analyst time 
Influenza vaccine 
PCV-13 vaccine 
PPSV-23 vaccine 
Whiteboards 
Nursing Research Office Fee 
Launch meeting materials 
 
Total 
 
$0 (already SOC) 
$0 (already SOC) 
$0 (included in department duties) 
$0 (already routinely stocked) 
$0 (already routinely stocked) 
$0 (already routinely stocked) 
$40 
$500 
$0 (PowerPoint presentation) 
 
$540 
 
 
The timeline for this project spanned approximately 18 months from identification of the clinical 
problem to completion and write up of the project.  
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Figure 5: Timeline of QI project 
 
 
Section Four: Findings 
Results/Outcome 
The objective of this QI project was to improve percentages of documented vaccination 
in a particular subpopulation of patients. In order to determine whether or not the objective was 
met, the EMR was queried at baseline and predetermined time points after project launch. The 
analysis consisted of a simple comparison between pre and post intervention documented 
vaccination rates.  
This project endeavored to answer the clinical practice problem statement: In adult 
patients on immunosuppressive medications, how do prepopulated orders attached to care gap 
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alerts in the EMR and optimization of workflow using a centralized notification board affect 
levels of vaccination coverage? The answer is that during the intervention period, levels of 
documented vaccination increased. The four, eight, and 12 week data are included in Figure 6 
and show that compared to baseline, documented influenza, PCV13, and PPSV23 vaccination 
increased by 46.6%, 29.4%, and 22.4%, respectively. 
Figure 6: Percent of patients up to date on vaccinations
 
Limitations 
Similar to other QI projects that used multiple interventions (Chow & Shojania, 2017; S. 
Garg et al., 2018; Harris et al., 2015; Parker et al., 2013; Sheth et al., 2017), the design of this 
project made it impossible to determine how much of each intervention contributed to the 
outcomes. What can be learned from this is that multi-component approach is important to 
optimizing results in this type of QI project.  
Other factors beyond the interventions may have influenced the outcomes: the emergence 
of covid-19, a novel coronavirus, which may have increased awareness of respiratory illness, 
leading to an increased demand for influenza and pneumococcal vaccines by consumers; a severe 
influenza season, leading to more demand for vaccinations from patients; unavailability of 
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PCV13 vaccine for one week in January due to supply issues; launch of a statewide vaccination 
database, making incorporation of outside records easier than during the baseline data gathering 
period; MA turnover within the department; and the creation of workgroup “pods” within the 
department leading to increased interaction between prescribers and MAs. 
One of the potential barriers identified prior to project launch was provider confusion 
regarding vaccine scheduled. This barrier was not addressed as part of the project, however, 
independently and during the project time period, exam room signage reminding providers about 
pneumococcal vaccinations was installed throughout the department.  
 
Section Five: Recommendations and implications for practice 
Project Summary, Discussion and Conclusions 
This project used a team approach, orders attached to a care gap alert, and a new 
workflow process to increase documented vaccination in an immunosuppressed population. The 
increases seen were substantial and comparable to similar projects (Bays et al., 2016; S. Garg et 
al., 2016, 2018; Goodson et al., 2018; Sheth et al., 2017). Although vaccination rates did not 
reach goals established by Healthy People 2020, the project was still successful in that any 
increase equates to increased protection for the targeted population.  
Implications for Practice 
In 2005, the American Association of Colleges of Nursing created a task force to develop 
expectations surrounding the Doctor of Nursing Practice (DNP) curriculum. One year later the 
task force issued a report which outlined eight essentials of doctoral education for advanced 
nursing practice. These essentials “address the foundational competencies that are core to all 
advanced practice nursing roles” and cover a wide range of topics including technology, 
leadership, scholarship, collaboration, and others (American Association of Colleges of Nursing, 
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2006). Of the eight essentials, the two most relevant to this project are Essential II 
(Organizational and System Leadership for Quality Improvement and Systems Thinking) and 
Essential VII (Clinical Prevention and Population Health for Improving the Nation’s Health). 
The relevance of Essential II stems from the fact that it specifically includes quality 
improvement as an avenue to increase patient safety as well as the mandate to ensure 
accountability for the safety of specific patient populations (American Association of Colleges of 
Nursing, 2006). The specific patient population in this case was immunocompromised adults, 
and patient safety was increased via protection from vaccine-preventable illnesses. Essential VIII 
broadens the scope of Essential II, in this case recognizing that increasing vaccination rates in 
any individual, in this case adult rheumatology patients, protects not just the person getting the 
vaccine but also increases the chances of achieving herd immunity, therefore protecting greater 
populations.  
The satisfaction of two essentials for DNP practice reflects the rationale for continuation 
and possible expansion of the QI project. The interventions that led to an increase in vaccination 
rates are simple and cost very little, if anything, to maintain. Care gap alerts (with attached 
orders) are incorporated into the EMR and the white boards are now part of everyday use in the 
department. Although the specific team that worked on this project has no plans to meet 
regularly, other projects using the team approach, such as a vaccine reconciliation project and an 
EMR optimization project, have already been launched using the same model that was used for 
this project.  
Improving vaccination rates satisfies much of the mission statement of the health care 
system in which this project took place (“To provide better care of the sick, investigation in their 
problems and further education of those who serve”). Although not research or an 
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“investigation” into patients’ problems, this project did result in better care of the sick partly 
through further education of rheumatology caregivers. Therefore the continuation of the project 
is reasonable and aligns with the framework of the larger hospital system. Future phases 
incorporating the human papilloma virus (HPV) and/or shingles vaccines will need to involve 
specialists who see patients in the appropriate age groups. The HPV group might have a better 
chance for success if physicians, APPs, nurses and MAs from the pediatric rheumatology 
department were invited to participate, along with the lupus clinic in adult rheumatology since 
their patient population includes a large number of young women. In contrast, shingles 
vaccination is recommended for individuals 50 years of age and older, so including the metabolic 
bone group – which treats patients with osteoporosis – would make sense.  
Identify methods for dissemination 
Immunosuppression is not unique to rheumatology. Many of the immunosuppressant medications 
used to treat rheumatic diseases are also approved for non-rheumatic autoimmune diseases; it follows that 
patients being treated for these conditions are just as vulnerable vaccine-preventable infections as 
rheumatology patients. Since this QI project proved to be successful, the author will offer to present the 
results at grand rounds in other departments such as dermatology, gastroenterology, neurology, and 
oncology. Although only a local-level effort, the impact could prove to be large given the size of the 
healthcare system and the numbers of patients treated.  
As evidenced by the number of abstracts involving vaccine research at the ACR annual meetings 
over the last decade, immunization of patients with IMIDs is a topic which generates much interest 
among providers. Submitting an abstract to this meeting is also a possible method of dissemination of the 
results of this project. The ACR has a sub-organization called the Association of Rheumatology 
Professionals which includes social workers, psychologists, physical therapists, occupational therapists, 
basic scientists, nurses, pharmacists, nurse practitioners, and physician assistants. Accepted abstracts are 
displayed in one hall, ensuring they are available to all meeting attendees, making this dissemination 
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method very impactful. By reaching all members of the health care team the authors will be able to catch 
the attention of anyone interested in improving rates of vaccination coverage in rheumatology patients. 
Another possibility for dissemination is a poster or oral presentation at the Rheumatology Nurses 
Society or Rheumatology Advanced Practice Providers annual meetings. These meetings attract a more 
focused audience so would not reach as wide a group as a poster at the ACR, but presenting at these 
venues would still be impactful as many nurses and advanced practice providers may feel more 
comfortable approaching the author with questions at a meeting focused on their specialties.  
Finally, submission to a journal such as Arthritis Care & Research or the Journal of 
Rheumatology would be another way to reach an audience interested in improving rates of vaccination 
coverage in immunosuppressed patients. 
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Appendix A: Evaluation Table of Articles 
Citation Design/Methods Sample/Setting Major Variables Outcome 
Measurement 
Data Analysis Findings LoE Quality of 
Evidence 
Garg (2018). 
The Journal of 
Rheumatology, 
1656-1662 
Multifaceted QI; pre-
intervention surveys; 
pre-visit planning, 
day-of-visit planning, 
weekly review of 
data, monthly 
feedback sessions; 
EMR-generated 
reminders. 
SLE patients, adult 
rheumatology, 
Emory University; 
25 weeks 
Vaccination rates 
PCV13, PPSV23, 
PCV13+PPSV23 
Pre- and post-
intervention 
vaccination 
rates 
Vaccination 
rates, refusal 
rate, 
pneumococcal 
pneumonia-
related 
hospitalization. 
PCV13 2 → 
39%, PPSV23 
8→ 56%, 
combination 10 
→ 59%. 
Hospitalization 
3.6 → 2.2%. 
VI Excellent 
Baker (2016). 
The Journal of 
Rheumatology, 
1030-1037 
System-level 
intervention 
including multiple QI 
strategies. Electronic 
reminders with 
linked order sets, 
audit & feedback, 
patient outreach. 
RA patients, adult 
rheumatology, 
Northwestern 
Medical Group; 12 
months. N=1255. 
PCV13, PPSV23, 
flu, HZ vaccination 
rates 
Pre- and post-
intervention 
vaccination 
rates. 
EMR 
vaccination 
rates, refusal 
rates (PCV13, 
PPSV23, HZ); 
self-reported flu 
vaccination rates 
from a random 
sample of RA 
patients. 
PCV13/PPSV23 
29→46%; flu 
79→78%; zoster 
2→4%. 
VI Excellent 
except flu, 
which was 
self-reported. 
Karr (2016). 
Ochsner Journal, 
90-95 
QI project to 
determine perceived 
barriers and improve 
process; order set in 
EMR. 
IBD providers, 
adult 
gastroenterology, 
Ochsner Clinic; 2 
months. N=13. 
HAV, HBV, HPV, 
meningococcus, 
MMR, PCV13, 
PPSV23, TDaP, 
HZ, flu vaccination 
rates 
Provider 
satisfaction 
with order set. 
Qualitative 
report of survey 
results. 
6 of 10 
respondents 
reported an 
increase in 
vaccinations due 
to order set. 
VI Fair; pre- and 
post-surveys 
differed. 
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Citation Design/Methods Sample/Setting Major Variables Outcome 
Measurement 
Data Analysis Findings LoE Quality of 
Evidence 
Desai (2013). 
Arthritis & 
Rheumatism, 
39-47 
QI project using 
paper reminder form 
generated from data 
in EMR. 
Adult rheumatology 
patients receiving 
IS medications at 5 
outpatient clinics; 
38 months. 
N=3,717. 
Vaccination rates 
for patients of 
providers who 
received 
intervention vs 
providers who 
didn’t. 
Patients UTD 
with 
pneumococcal 
vaccination 
Pneumococcal 
vaccination 
rates. 
% of patients 
UTD with 
pneumococcal 
vaccination 
68→80% 
(intervention) vs 
52→52% 
(control). 
VI Excellent 
Ledwich (2009). 
Arthritis & 
Rhematism, 
1505-1510 
QI project using BPA 
in EMR. 
Adult rheumatology 
patients receiving 
IS medications at 2 
academic settings; 
3 months. 
PCV13, PPSV23, 
flu vaccination rate 
change at each site 
and between the 
two sites (site 1 
physician based 
model, site 2 nurse 
based model). 
Pre- and post- 
intervention 
vaccination 
rates. 
Vaccination 
rates using chi-
square test; 
demographics 
compared with 
Wilcoxon’s 
analysis, chi-
square test, 
Fisher’s exact. 
Flu vaccination 
43→60% (site 1), 
69→82% (site 2). 
Pneumococcal 
vaccination 
15→39% (site 1), 
47→57% (site 2). 
VI Excellent 
Desai (2011). 
Rheumatology, 
366-372 
Measure and improve 
PPSV23 vaccination 
in patients on IS 
medications. 
Adult patients 
receiving IS 
medications at 
Brigham & 
Women’s Hospital 
outpatient 
rheumatology 
clinic; 24 months. 
PPSV23 
vaccination status. 
Additional data 
included age, race, 
gender, diagnosis. 
Percentage of 
patients up to 
date with 
PPSV23, both 
generally and 
at initiation of 
IS medication. 
Descriptive 
analysis 
54% of patients 
on IS medication 
UTD on 
vaccination. 45% 
of patients newly 
started on IS 
medication UTD. 
VI Excellent 
except for data 
gap (IV 
medications) 
Sheth (2017). 
The Journal of 
Rheumatology, 
11-17 
QI project to improve 
HZ vaccination using 
Intervention: BPA in 
EMR, modified clinic 
workflow; provider, 
staff, patient 
education; physician 
feedback and 
assessment. 
Adult patients with 
RA at 13 UPMC 
rheumatology 
outpatient clinics; 
12 months 
HZ vaccine 
administration, 
prescription, 
deferred, declined. 
Pre- and post-
intervention 
vaccination 
rates. 
Number of 
vaccinations or 
prescriptions for 
vaccinations 
given per total 
number of 
eligible patients 
with RA. 
Vaccination 
10→52%; 
vaccination + 
documentation 
28→73%. 
VI Moderate;  
42% of BPAs 
dismissed by 
physician. If 
included post- 
vax rate would 
have been 
25% (not 
52%). 
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Citation Design/Methods Sample/Setting Major Variables Outcome 
Measurement 
Data Analysis Findings LoE Quality of 
Evidence 
Harris (2015). 
Pediatrics, e680-
e686 
QI project to improve 
pneumococcal 
vaccination using 
provider education, 
posted algorithm, 
pre-visit planning, 
written reminders. 
Patients >2 years 
old at Children’s 
Hospital of 
Wisconsin 
rheumatology clinic 
who either had SLE 
or were on IS 
medications; 12 
months. 
PCV13 and PPV23 
rates stratified by 
diagnosis (JIA, 
SLE, and other) 
Pre- and post- 
intervention 
vaccination 
rates. 
# pts receiving 
PCV13/PPSV23 
(numerator), # 
eligible patients 
(denominator). 
Results: baseline 
cohort and all 
patients after 
baseline. 
PCV13 5 to 10% 
→ 46 to 56%.  
PPSV23 5 to 
16% → 25 to 
46%. 
VI Excellent 
Parker (2013). 
Inflammatory 
Bowel Disease, 
1809-1814 
QI project to increase 
flu and PPSV23 
vaccination in 
immunosuppressed 
patients with IBD 
using PDSA. 
Interventions: paper 
update form for 
patients, offer 
vaccines in clinic. 
Adult 
immunosuppressed 
IBD patients at the 
Dartmouth-
Hitchcock IBD 
center. 
Flu vaccination and 
PPSV23 rates. 
Proportion of 
patients who 
received flu 
vaccination and 
PPSV23 
previously 
compared with 
during the 
intervention. 
Self-reported 
baseline 
vaccination 
rates. Flu 
vaccination and 
PPSV23 rates. 
Flu vaccine 
54→81%. 
PPSV23 
31→54%. 
VI Very good; 
self-report of 
prior 
vaccination 
not confirmed. 
Chow (2017). 
The Journal of 
Rheumatology, 
1304-1310 
QI project to increase 
flu vax in pts with 
IMIDs. Interventions: 
standardization of 
documentation, 
patient information, 
reminders to 
pharmacists on 
DMARD 
prescriptions. 
Adult 
immunosuppressed 
patients at 
Sunnybrook Health 
Sciences Center. 
Flu vaccination 
rates. 
Proportion of 
patients who 
received 
intervention 
materials; 
proportion of 
patients who 
received flu 
vaccine. 
Number of 
patients 
receiving 
vaccine 
(numerator), 
number of 
eligible patients 
(denominator) 
Flu vaccine 
40→65% 
VI Excellent 
Abbreviations: BPA: best practice alert; EMR: electronic medical record; flu: influenza; HAV: hepatitis A virus; HBV: hepatitis B virus, HPV: human papilloma virus; 
HZ: Herpes zoster; IBD: inflammatory bowel disease; IS: immunosuppressive; IV: intravenous; JIA: juvenile idiopathic arthritis; LoE: level of evidence; MMR: 
measles, mumps, rubells; PCV13 pneumococcal conjugate vaccine; PDSA: plan do study act; PPSV23 pneumococcal polysaccharide vaccine; RA: rheumatoid arthritis; 
SLE: Systemic Lupus Erythematosus;  TDaP: tetanus, diphtheria, acellular pertussis;  QI: Quality Improvement 
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Rheum specific          
Pneumonia          
Flu          
Intervention:          
   Process change          
   EMR          
   Team approach          
Highest % 
Improvement 
49 17 N/A 12 24 N/A 42 21 27 25 
 
 
 
Abbreviations: Rheum: rheumatology; Pneumonia: pneumonia vaccine (either PPSV23, PCV13, or both); Flu: influenza 
vaccine; EMR: electronic medical record. 
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Appendix C: Synthesis Table of ACR Abstracts 
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Vaccine P P P P HZ P P P P P HZ P P 
PDSA             
Intervention:             
   Process change             
   EMR             
   Team approach             
Highest % 
Improvement 
18 39 84 15 12 48 40 57 72 18 17 30 12 
 
 
 
Abbreviations: P: pneumonia vaccine (either PPSV23, PCV13, or both); HZ: herpes zoster vaccine; EMR: electronic 
medical record. 
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Appendix D: New Idea Scorecard: Improving Vaccination Coverage in Immunosuppressed Rheumatology Patients (Fraser, 2019) 
 Relative 
Advantage 
Simplicity Compatibility Trialability Observability 
Provider uses 
CGA  
     
Whiteboard 
(provider use) 
     
Whiteboard 
(MA use) 
     
 
 
Documentation      
ITD builds way 
for VIS to print 
in AVS 
     
 
Definitions: 
Relative Advantage – the degree to which an innovation is perceived as better than the idea it supersedes 
Simplicity – the degree to which an innovation is perceived as simple to understand and use 
Compatibility – the degree to which an innovation is perceived as being consistent with the existing values, experiences, 
beliefs, and needs of potential adopters 
Trialability – the degree to which an innovation can be tested on a small scale 
Observability – the degree to which the use of an innovation and the results it produces are visible to those who should 
consider it 
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How to Use the Scorecard 
 The exercise is done as a table exercise with people sitting at tables. 
 Write the name of a specific change/innovation in the box at the left. 
 Have each person independently rate the change from the “spread target” point of view.  Use a 1–5 scale: 
1 — change is very weak relative to this attribute 
3 — change is okay relative to this attribute 
5 — change is very strong relative to this attribute 
 After each table has had a chance to evaluate the change, have a report out and group discussion of how the changes were 
rated in relation to each of the attributes.  Pay particular attention to: (1) any item where there are significant differences in 
scoring among the group (e.g., 2s and 5s on the same item); and (2) scores of 1 or 2 for any of the items. 
 Use these discussions to plan how to overcome barriers that are identified and develop an action plan for addressing these 
barriers. 
 
Teaching point is that each change differs on how easily it is likely to spread.  Some may require specific communication 
messages or specific actions that a team can take to make it more likely to spread (e.g., make sure the test is visible and testable by 
others, simplify the instructions on how to do the change). 
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Appendix E: Percent of patients up to date on vaccinations 9/1/17 – 8/31/18 (by medication) 
 PCV13 PPSV23 Flu 
Abatacept 
Adalimumab 
Anakinra 
Azathioprine 
Belimumab 
Certolizumab 
Cyclophosphamide 
Etanercept 
Golimumab 
Infliximab 
Leflunomide 
Methotrexate 
Mycophenolate 
Rituximab 
Sarilumab 
Secukinumab 
Tocilizumab 
Tofacitinib 
Ustekinumab 
 
12.87 
6.01 
7.27 
11.63 
9.52 
12.5 
13.89 
6.59 
2.27 
18.18 
12.57 
12.26 
12.05 
13.68 
20 
3.17 
7.69 
1.8 
11.11 
 
25.74 
17.84 
14.55 
32.3 
38.1 
18.75 
16.67 
10.85 
9.09 
43.8 
25.44 
24.47 
35 
32.42 
60 
26.98 
17.31 
18.92 
16.67 
 
14.85 
7.95 
3.64 
7.49 
4.76 
6.25 
8.33 
4.65 
4.55 
19.83 
14.04 
11.67 
9.77 
11.58 
20 
4.76 
8.65 
2.7 
0 
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Appendix F: Literature Search Results 
Wateska, A.R., Nowalk, M.P., 
Lin, C.J., Harrison, L.H., 
Schaffner, W., Zimmerman, 
R.K., Smith, K.J. 
An intervention to improve pneumococcal 
vaccination uptake in high risk 50-64 year 
olds vs. expanded age-based 
recommendations: an exploratory cost-
effectiveness analysis 
(2019) Human Vaccines and 
Immunotherapeutics, 15 (4), pp. 863-872.  
NO Financial info 
Austin, B., Morgan, H. Improving Human Papillomavirus Vaccine 
Uptake in the Family Practice Setting 
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intervention, web-
based, toolkits 
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Sandler, D.S., Ruderman, E.M. 
A multifaceted intervention to improve 
influenza, pneumococcal, and herpes zoster 
vaccination among patients with rheumatoid 
arthritis 
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Sidani, M., Harris, J., Zoorob, 
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Paul M 
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Reviews 
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Thomas RE, Lorenzetti DL Interventions to increase influenza 
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in the community 
(2018) Cochrane Database of Systematic 
Reviews 
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Liss DT, Baker DW 
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among patients with rheumatoid arthritis.  
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NO  pt self-reported data 
Kirchner E, Ruffing V Barriers to Immunizations and Strategies to 
Enhance Immunization Rates in Adults with 
Autoimmune Inflammatory Diseases. 
Rheum Dis Clin North Am. 2017 
Feb;43(1):15-26. doi: 
10.1016/j.rdc.2016.09.004. Review. PMID: 
27890171  
NO historical review 
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Improving pediatric immunization rates: 
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continuous quality improvement project. 
Fam Med. 2014 Sep;46(8):631-5. PMID: 
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NO Focus on teaching 
residents QI; 
pediatrics 
Gurvits GE, Lan G, Tan A, 
Weissman A 
Vaccination practices in patients with 
inflammatory bowel disease among general 
internal medicine physicians in the USA. 
Postgrad Med J. 2017 Jun;93(1100):333-
337. doi: 10.1136/postgradmedj-2016-
134266. Epub 2016 Oct 12. PMID: 
27733673 
NO Survey of physician 
practices/knowledge 
Maldonado AQ, Johnson D, 
Trofe-Clark J 
Barriers to vaccination in renal transplant 
recipients. 
Transpl Infect Dis. 2017 Oct;19(5). doi: 
10.1111/tid.12749. Epub 2017 Sep 4. 
PMID: 28714222  
NO Identifies barriers, 
no interventions 
Whitaker JA, von Itzstein MS, 
Poland GA 
Strategies to maximize influenza vaccine 
impact in older adults. 
Vaccine. 2018 Sep 25;36(40):5940-5948. 
doi: 10.1016/j.vaccine.2018.08.040. Epub 
2018 Aug 25. Review. PMID: 30153995  
NO Study compared 
efficacy of different 
flu vaccines 
Garg M, Mufti N, Palmore TN, 
Hasni SA 
Recommendations and barriers to 
vaccination in systemic lupus erythematosus. 
Autoimmun Rev. 2018 Oct;17(10):990-
1001. doi: 10.1016/j.autrev.2018.04.006. 
Epub 2018 Aug 11. Review. PMID: 
30103044  
NO Summary of 
recommendations 
Lawson EF, Trupin L, Yelin 
EH, Yazdany J. 
Reasons for failure to receive pneumococcal 
and influenza vaccinations among 
immunosuppressed patients with systemic 
lupus erythematosus. 
Semin Arthritis Rheum. 2015 
Jun;44(6):666-71. doi: 
10.1016/j.semarthrit.2015.01.002. Epub 
2015 Jan 22. PMID: 25701500  
NO Patient survey 
Laniosz V, Lehman JS, Poland 
GA, Wetter DA 
Literature-based immunization 
recommendations for patients requiring 
immunosuppressive medications for 
autoimmune bullous dermatoses. 
Int J Dermatol. 2016 Jun;55(6):599-607. 
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NO Compares 
effectiveness of 
various teaching 
methods. 
Cockman P, Dawson L, Mathur 
R, Hull S 
Improving MMR vaccination rates: herd 
immunity is a realistic goal. 
BMJ. 2011 Oct 4;343:d5703. doi: 
10.1136/bmj.d5703. PMID: 21971162  
NO Financial incentives 
to practices in 
London 
Cadena J, Prigmore T, Bowling 
J, Ayala BA, Kirkman L, 
Parekh A, Scepanski T, 
Patterson JE. 
Improving influenza vaccination of 
healthcare workers by means of quality 
improvement tools. 
Infect Control Hosp Epidemiol. 2011 
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